First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study

RationaleThe clinical impact of a novel mechanical thrombectomy strategy, which integrates distal access with flow reversal and flow arrest via a distal balloon, all within a single procedure [Safety and Efficacy of the overall throMbectomy system for sTroke (SEMTiC) strategy], has not been tested.A...

Full description

Saved in:
Bibliographic Details
Main Authors: Luís San Román, Laura Ludovica Gramegna, Sara Pich, Laura Domingo-Rodriguez, Marta Duran, Lluís Duocastella, Juan Macho
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1537008/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850253511868022784
author Luís San Román
Laura Ludovica Gramegna
Sara Pich
Laura Domingo-Rodriguez
Marta Duran
Lluís Duocastella
Juan Macho
author_facet Luís San Román
Laura Ludovica Gramegna
Sara Pich
Laura Domingo-Rodriguez
Marta Duran
Lluís Duocastella
Juan Macho
author_sort Luís San Román
collection DOAJ
description RationaleThe clinical impact of a novel mechanical thrombectomy strategy, which integrates distal access with flow reversal and flow arrest via a distal balloon, all within a single procedure [Safety and Efficacy of the overall throMbectomy system for sTroke (SEMTiC) strategy], has not been tested.AimThe SEMTiC-01 study is the first prospective, multicenter in vivo study evaluating the safety and efficacy of the combined thrombectomy system—iNedit, iNdeep, and iNtercept—in patients with acute ischemic stroke.Sample size estimatesThe study was designed with a sequential structure based on the efficacy endpoint (eTICI ≥2b) reported in the literature [71.1% with a 95% confidence interval of (68.5%, 73.8%)]. An interim analysis was set for 115 patients and a final analysis for 225 patients, ensuring 98% power at a one-sided 0.025 significance level, with a 2.6% non-inferiority margin and a 15% assumed withdrawal rate.DesignSEMTiC-01 is a prospective, multicenter, single-arm, open-label clinical safety and efficacy investigation.OutcomePrimary efficacy endpoint: expanded treatment in cerebral infarction score (eTICI) ≥2b revascularization within ≤ 3 stent retriever passes. Primary safety endpoint: monitoring serious adverse events within 24 h post-intervention and all-cause mortality at 90 days.
format Article
id doaj-art-099d88fbb2564c089ac997276209a879
institution OA Journals
issn 1664-2295
language English
publishDate 2025-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj-art-099d88fbb2564c089ac997276209a8792025-08-20T01:57:21ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-03-011610.3389/fneur.2025.15370081537008First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the studyLuís San Román0Laura Ludovica Gramegna1Sara Pich2Laura Domingo-Rodriguez3Marta Duran4Lluís Duocastella5Juan Macho6Department of Neuroradiology, Hospital Clinic, Barcelona, SpainVall d'Hebron Institut de Recerca, Vall d'Hebron Barcelona Hospital Campus, Barcelona, SpainiVascular, Barcelona, SpainiVascular, Barcelona, SpainiVascular, Barcelona, SpainiVascular, Barcelona, SpainDepartment of Neuroradiology, Hospital Clinic, Barcelona, SpainRationaleThe clinical impact of a novel mechanical thrombectomy strategy, which integrates distal access with flow reversal and flow arrest via a distal balloon, all within a single procedure [Safety and Efficacy of the overall throMbectomy system for sTroke (SEMTiC) strategy], has not been tested.AimThe SEMTiC-01 study is the first prospective, multicenter in vivo study evaluating the safety and efficacy of the combined thrombectomy system—iNedit, iNdeep, and iNtercept—in patients with acute ischemic stroke.Sample size estimatesThe study was designed with a sequential structure based on the efficacy endpoint (eTICI ≥2b) reported in the literature [71.1% with a 95% confidence interval of (68.5%, 73.8%)]. An interim analysis was set for 115 patients and a final analysis for 225 patients, ensuring 98% power at a one-sided 0.025 significance level, with a 2.6% non-inferiority margin and a 15% assumed withdrawal rate.DesignSEMTiC-01 is a prospective, multicenter, single-arm, open-label clinical safety and efficacy investigation.OutcomePrimary efficacy endpoint: expanded treatment in cerebral infarction score (eTICI) ≥2b revascularization within ≤ 3 stent retriever passes. Primary safety endpoint: monitoring serious adverse events within 24 h post-intervention and all-cause mortality at 90 days.https://www.frontiersin.org/articles/10.3389/fneur.2025.1537008/fullmechanical thrombectomyacute ischemic strokeballoon guide catheterdistal aspiration catheterendovascular stroke treatment
spellingShingle Luís San Román
Laura Ludovica Gramegna
Sara Pich
Laura Domingo-Rodriguez
Marta Duran
Lluís Duocastella
Juan Macho
First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
Frontiers in Neurology
mechanical thrombectomy
acute ischemic stroke
balloon guide catheter
distal aspiration catheter
endovascular stroke treatment
title First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
title_full First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
title_fullStr First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
title_full_unstemmed First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
title_short First prospective, single-arm, multicenter study to evaluate safety and efficacy of the overall thrombectomy system -iNedit, iNdeep, and iNtercept- for acute ischemic stroke. Rationale beyond the study
title_sort first prospective single arm multicenter study to evaluate safety and efficacy of the overall thrombectomy system inedit indeep and intercept for acute ischemic stroke rationale beyond the study
topic mechanical thrombectomy
acute ischemic stroke
balloon guide catheter
distal aspiration catheter
endovascular stroke treatment
url https://www.frontiersin.org/articles/10.3389/fneur.2025.1537008/full
work_keys_str_mv AT luissanroman firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy
AT lauraludovicagramegna firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy
AT sarapich firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy
AT lauradomingorodriguez firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy
AT martaduran firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy
AT lluisduocastella firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy
AT juanmacho firstprospectivesinglearmmulticenterstudytoevaluatesafetyandefficacyoftheoverallthrombectomysystemineditindeepandinterceptforacuteischemicstrokerationalebeyondthestudy